MedPath

Removal of Uremic Toxins With Nocturnal Dialysis Versus Standard Dialysis

Not Applicable
Completed
Conditions
Chronic Renal Failure
Registration Number
NCT00766792
Lead Sponsor
University Hospital, Ghent
Brief Summary

Dialysis patients, who decide to switch from standard dialysis (3 times 240-270 min/week) to nocturnal dialysis (3 times 480 min/week), will be followed. In parallel a control group with patients staying on standard dialysis will be followed. The study will last 30 weeks. During this period blood samples (pre- and post-dialysis: 10 times; inlet and outlet of dialyzer: 3 times) will be collected on predetermined time points. Concentration of several uremic retention solutes will be determined.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • age > 18 years
Exclusion Criteria
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
To evaluate what is more effective for removal of uremic toxins - nocturnal versus standard dialysis?30 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Ghent

🇧🇪

Ghent, Belgium

University Hospital Ghent
🇧🇪Ghent, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.